These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1549027)

  • 21. Plasminogen activator levels in plasma and urine during exercise and oral contraceptive use.
    Hedlin AM; Milojevic S; Korey A
    Thromb Haemost; 1978 Jun; 39(3):743-50. PubMed ID: 705703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nisoldipine in the therapy of stable exercise angina: evaluation of its efficacy in ergometric tests compared with propranolol].
    Petretta M; Morgano G; Arrichiello P; Breglio R; Lanzillo T; Mazza F; Bonaduce D
    G Ital Cardiol; 1990 Jun; 20(6):518-25. PubMed ID: 2227221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Verapamil versus propranolol in stable effort angina. Randomized, crossed, double-blind study].
    Lesbre JP; Lalau JD; Jaubourg ML; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1988 Apr; 37(4):205-10. PubMed ID: 3285763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proactivator and activator levels of plasminogen in plasma as measured by caseinolysis.
    Kline DL; Reddy KN
    J Lab Clin Med; 1977 May; 89(5):1153-8. PubMed ID: 140200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator.
    Stibbe J; Kluft C; Brommer EJ; Gomes M; de Jong DS; Nauta J
    Eur J Clin Invest; 1984 Oct; 14(5):375-82. PubMed ID: 6437836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute effect of smoking on fibrinolysis: increase in the activity level of circulating extrinsic (tissue-type) plasminogen activator.
    Allen RA; Kluft C; Brommer EJ
    Eur J Clin Invest; 1984 Oct; 14(5):354-61. PubMed ID: 6437833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some observations on the release of extrinsic and intrinsic plasminogen activators during exercise in man.
    Marsh N; Gaffney P
    Haemostasis; 1980; 9(4):238-47. PubMed ID: 7190533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Both atenolol and propranolol blunt the fibrinolytic response to exercise but not resting fibrinolytic potential.
    Fernhall B; Szymanski LM; Gorman PA; Kamimori GH; Kessler CM
    Am J Cardiol; 2000 Dec; 86(12):1398-400, A6. PubMed ID: 11113426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoselective hemodynamic effects of (R)-and (S)-propranolol in man.
    Stoschitzky K; Lindner W; Rath M; Leitner C; Uray G; Zernig G; Moshammer T; Klein W
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):474-8. PubMed ID: 2739756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proceedings: Hemophilia: modified by a post-exercise plasminogen activator.
    Hampton JW; Weidenbach A; Skye GE; Rubenstein C; Taylor FB
    Thromb Diath Haemorrh; 1975 Nov; 34(2):612. PubMed ID: 810
    [No Abstract]   [Full Text] [Related]  

  • 31. Exercise induces pentane production and neutrophil activation in humans. Effect of propranolol.
    Pincemail J; Camus G; Roesgen A; Dreezen E; Bertrand Y; Lismonde M; Deby-Dupont G; Deby C
    Eur J Appl Physiol Occup Physiol; 1990; 61(3-4):319-22. PubMed ID: 2178091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects.
    Fujimura A; Kumagai Y; Sugimoto K; Nakashima H; Kajiyama H; Ebihara A; Ohashi K
    Eur J Clin Pharmacol; 1990; 38(2):133-7. PubMed ID: 2338109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis.
    Jørgensen M; Mortensen JZ; Madsen AG; Thorsen S; Jacobsen B
    Scand J Haematol; 1982 Sep; 29(3):217-23. PubMed ID: 6890710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of plasminogen activator activity in human arteries and veins.
    Ljungnér H; Bergqvist D
    Thromb Res; 1983 Sep; 31(6):779-86. PubMed ID: 6685929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of local exercise and vessel occlusion on fibrinolytic activity.
    Rennie JA; Bennett B; Ogston D
    J Clin Pathol; 1977 Apr; 30(4):350-2. PubMed ID: 856879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do low and moderate doses of acetylsalicylic acid affect tissue plasminogen activator at rest and after exercise?
    Winther K; Gleerup G; Husted S
    Am J Cardiol; 1994 Apr; 73(9):703-5. PubMed ID: 8166070
    [No Abstract]   [Full Text] [Related]  

  • 37. Amalfi to Washington D. C.--twenty years of plasminogen activator research.
    Antalis TM; Bugge TH; Lawrence DA; Netzel-Arnett S; Schwartz BS; Strickland DK
    Thromb Haemost; 2005 Apr; 93(4):625-6. PubMed ID: 15841304
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on plasminogen activator. I. Human urine and corpse heart blood, fibrin plate method (author's transl)].
    Shiba T; Takeuchi S; Matsumoto M; Sanada T; Terashima T
    Nihon Ketsueki Gakkai Zasshi; 1974 Dec; 37(6):853-62. PubMed ID: 4480656
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral stanozolol: effects on plasma and saliva fibrinolysis and plasma viscosity in normal males.
    Small M; McArdle BM; Lowe GD; Brodie MJ; Forbes CD; Prentice CR
    Thromb Res; 1983 Jul; 31(2):233-7. PubMed ID: 6685353
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasminogen activator release assays.
    Nilsson IM
    Acta Clin Belg; 1977; 32(6):391-7. PubMed ID: 616750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.